Pacific Biosciences of California (PACB) Misses Q4 EPS by 2c

Article Related Press Releases (1) Stock Quotes (1) Comments (0)

Pacific Biosciences of California, Inc. (NASDAQ: PACB) reported Q4 EPS of ($0.39), $0.02 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $5.9 million versus the consensus estimate of $4.38 million.

For earnings history and earnings-related data on Pacific Biosciences of California, Inc. (PACB) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
• Taomee Holdings Ltd. (TAOM) Misses Q1 EPS by 2c; Guides Q2 Sales
• Mentor Graphics Corp (MENT) Tops Q1 EPS by 5c; Guides Q2, FY14

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?